Semiconductor giant Advanced Micro Devices (AMD) reported better-than-expected Q4 2024 earnings and revenue. However, the 69% ...

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 21.64% Upside As of ...

The S&P 500 (SP500) is coming off back-to-back 20% plus return years and Wells Fargo says a three-peat is unlikely. Learn ...

Wells Fargo (NYSE:WFC) began coverage on DENTSPLY SIRONA (NASDAQ: NASDAQ:XRAY) shares, assigning an Equal Weight rating and setting a price target of $20.00. The new rating comes as DENTSPLY SIRONA's ...

Visa is preparing to offer account-to-account (A2A) payment services in 2025. The company plans to rollout its A2A platform ...

The Dow Jones Industrial Average shed 165.35 points, or 0.37%, closing at 44,546.08. The S&P 500 ticked down 0.01% to ...

Money can’t buy you love — or as much cocoa as it used to, with adverse weather denting West African crops and chocolatiers ...

It will be harder to find sweet deals on chocolate this Valentine’s Day. In fact, the cost of chocolate might put a bitter ...

T. Rowe Price Group (NASDAQ:TROW – Get Free Report) had its price objective decreased by investment analysts at Wells Fargo & Company from $118.00 to $116.00 in a research report issued on ...

It will be harder to find sweet deals on chocolate this Valentine's Day. In fact, the cost of chocolate might put a bitter ...

Cocoa prices rose to record highs last year amid a global supply shortage. Chocolate makers have raised their retail prices to compensate.

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have been given an average rating of “Hold” by the eleven analysts that are presently covering the company, Marketbeat reports.